Schmidt, M.* et al. Epidemiologic risk factors in a comparison of a Barrett Esophagus Registry (BarrettNET) and a case-control population in Germany. Cancer Prev. Res. 13, 377-384 (2020)
Schellnegger, R.* et al. Goblet cell ratio in combination with differentiation and stem cell markers in barrett esophagus allow distinction of patients with and without esophageal adenocarcinoma. Cancer Prev. Res. 10, 55-66 (2017)
Nagaraja, G.M.* et al. Silencing hsp25/hsp27 gene expression augments proteasome activity and increases CD8+ T-cell-mediated tumor killing and memory responses. Cancer Prev. Res. 5, 122-137 (2012)